Predictmedix Inc (CSE:PMED) (OTCQB:PMEDF) said Wednesday that it acquired telemedicine remote patient monitoring platform MobileWellbeing, which will be integrated with the company's existing artificial intelligence-driven rapid screening system for infectious diseases, including coronavirus (COVID-19).
The Toronto, Canada-based company said the MobileWellbeing platform will also fuse with Predictmedix's screening modules for impairment and mental illness.
Predictmedix said MobileWellbeing has demonstrated its value in multiple programs over the years and shown benefits such as improved patient health and driven down the cost for care through remote monitoring. The technology has been successfully used at Arnprior District Memorial Hospital for Chronic Obstructive Pulmonary Disease in Ottawa, by the nrursing department in Algonquin College, and StonyBrook Hospital in New York.
MobileWellbeing has a robust set of features such as Assisted Monitoring that allows for data collection, transmission, evaluation, notification and intervention at home, or through kiosks that might be especially useful in long term care and retirement community settings.
The Interactive Voice Response System also gives patients the accessibility to interact with the system without the need for internet connected devices. This is a key consideration given some remote regions where connectivity remains a major issue.
In a statement, Predictmedix COO Rahul Kushwah said: “We are excited to roll in the MobileWellbeing business that is already working with the healthcare system in both Canada and the US. Its presence in these health care sectors will provide enhanced credibility to future clients as Predictmedix expands its market reach.”
He added: “The key to getting back to work, back to school, back to business, is knowing when someone is potentially infected, taking the appropriate safety measures immediately, then monitoring and supporting these individuals to ensure their recovery from COVID-19 and the emotional toll are professionally managed. So, when it’s safe for them to go back to work, they are healthy and ready.”
Dr Kushwah said the features offered by MobileWellbeing allows the company to align the right telemedicine tools for each type of user and for the company’s three products:
- Infectious disease screening (including COVID-19)
- Cannabis and alcohol impairment screening
- Mental illness screening
“I am very excited to be part of the Predictmedix team as their vision of leading the future in impairment detection and healthcare screening aligns well with the MobileWellbeing remote monitoring platform we have developed over many years,” said MobileWellbeing founder CEO Rajiv Muradia. “The combined solution will now allow us to take healthcare delivery to the next level.”
Contact the author Uttara Choudhury at [email protected]
Follow her on Twitter: @UttaraProactive
